This product is a hypoglycemic drug that can reduce fasting and postprandial hyperglycemia in patients with type 2 diabetes, and can reduce HbAlc by 1% to 2%. Its mechanism of lowering blood sugar is: 1. Increase the sensitivity of peripheral tissues to insulin and increase insulin-mediated glucose utilization. 2. Increase the utilization of glucose by non-insulin-dependent tissues, such as the brain, blood cells, renal medulla, intestines, skin, etc. 3. Inhibit hepatic gluconeogenesis and reduce hepatic glucose output. 4. Inhibit intestinal wall cells from taking up glucose. Unlike the action of insulin, this product has no effect on promoting fat synthesis, has no obvious hypoglycemic effect on normal people, and generally does not cause hypoglycemia when used alone for type 2 diabetes.

Histamine H2 receptor antagonist, which has an inhibitory effect on the secretion of gastric acid and pepsin and can reduce the production of gastric acid

Antacids, which neutralize stomach acid that has already been produced

Antacids, which neutralize stomach acid that has already been produced

Selective α1 receptor blockers can reduce peripheral vascular resistance and have a lowering effect on both systolic and diastolic blood pressure; they have the effect of relaxing bladder and prostate smooth muscles and can relieve symptoms of dysuria caused by benign prostatic hypertrophy.

Selective alpha 1 receptor blocker, which can reduce peripheral vascular resistance and lower both systolic and diastolic blood pressure; it can relax bladder and prostate smooth muscles and relieve dysuria symptoms caused by benign prostatic hypertrophy

This product is a selective alpha 1 receptor blocker that can reduce peripheral vascular resistance and has a lowering effect on both systolic and diastolic blood pressure; it has the effect of relaxing bladder and prostate smooth muscles and can relieve the symptoms of dysuria caused by benign prostatic hypertrophy.